Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-17-062984

Chief Operating Officer sold 4,000 shares at $7.00 ($28,000)

  • Chief Operating Officer acquired 4,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Capponi Vincent Chief Operating Officer 2017-11-27 Sale −4,000 $7.00 $28,000 271,062 D
Capponi Vincent Chief Operating Officer 2017-11-27 Option exercise +4,000 $4.20 $16,800 275,062 D
Derivatives
Capponi Vincent Chief Operating Officer 2017-11-27 Option exercise · Stock Option (Right to Buy) −4,000 12,000 D
Open-market sales · 4,000 sh · avg $7.00 · $28,000
Loading xslF345X03/tv481084_4.xml…